Biogen: The Drive to Discover...The Drive to DeliverHome
SitemapContact Us
Investor Relations

Investor Relations


Stock Quote

Stock Chart
Financial News

Analysts

Investor FAQ

Financial Reports

SEC Filings

Fundamentals

Management

Information Requests

Audio Archives

Presentations

Calendar of Events

Email Alerts


Financial News

Notice to Readers: Information contained in our press releases should be considered accurate only as of the date of the release. Information in any press release may be superseded by more recent information we have disclosed in later press releases, filings with the Securities and Exchange Commission (“SEC”) or otherwise. Press releases may contain forward-looking statements based on the expectations of our management as of the date of the release. Actual results may materially differ based on several factors, including those described in the press releases and filings with the SEC.

11/11/2003
Biogen and IDEC Pharmaceuticals to Make Presentation at Credit Suisse First Boston Healthcare Conference
11/07/2003
Biogen Announces Webcast of Shareholder Meeting
10/28/2003
Total Revenues Up 19 Percent Year-Over-Year
10/09/2003
Biogen Schedules Third Quarter 2003 Financial Results for October 28, 2003
10/06/2003
IDEC Pharmaceuticals and Biogen Joint Proxy Statement Cleared by SEC
08/07/2003
IDEC Pharmaceuticals and Biogen Announce U.S. Federal Trade Commission Clearance of Merger
08/01/2003
FDA Approves Biogen's Large-Scale Manufacturing Facility for Commercial Production
07/24/2003
Biogen's Second Quarter 2003 Reported EPS Increased 31 Percent to $0.38; Second Quarter Operating EPS Increased 26 Percent to $0.39 over Second Quarter 2002
07/24/2003
Analysis Of ANTEGREN Phase III Induction Clinical Trial in Crohn's Disease Completed
07/11/2003
Biogen Schedules Second Quarter 2003 Financial Results for July 24, 2003
06/23/2003
Biogen & IDEC Announce Webcast of Today's (June 23) Investor Luncheon
06/23/2003
Biogen Reconfirms Full Year 2003 Revenue and EPS Guidance And Announces Revised Q2 EPS Outlook
06/23/2003
Biogen and IDEC Pharmaceuticals Announce Merger To Create a New Biotechnology Industry Leader
04/17/2003
Biogen Announces First Quarter 2003 Results
04/07/2003
Biogen Schedules First Quarter 2003 Financial Results for April 17, 2003
02/14/2003
Biogen Reports Updated Fourth Quarter and Full Year 2002 Results For Berlex Settlement
01/28/2003
Biogen Announces Fourth Quarter and Full Year 2002 Results
01/08/2003
Biogen Schedules Fourth Quarter/Year End 2002 Financial Results for January 28, 2003
10/18/2002
Biogen Announces Third Quarter 2002 Earnings
10/08/2002
Biogen Schedules Third Quarter 2002 Financial Results for October 18, 2002
07/18/2002
Biogen Announces Second Quarter 2002 Earnings Per Share of $0.29
06/07/2002
Biogen Announces Revised 2002 Financial Guidance
06/06/2002
Biogen to Provide Mid-Quarter Financial Update
04/24/2002
Biogen Announces First Quarter 2002 Earnings Per Share of $0.47
04/17/2002
Biogen Schedules First Quarter 2002 Financial Results for April 24, 2002
04/02/2002
Biogen Names John Palmer as Senior Vice President, Corporate Development
01/24/2002
Biogen Delivers on Operating Earnings Guidance of $1.90 Per Share After One- Time Charges
01/22/2002
Biogen Schedules Fourth Quarter & Year End 2001 Financial Results for January 24, 2002
12/21/2001
Biogen Says 2001 Revenues Will Exceed $1 Billion
11/01/2001
Biogen Cites Goal of Surpassing $2 Billion in Revenues in 2005
10/16/2001
Biogen Announces Third Quarter 2001 Earnings Per Share Increased to $0.46 From $0.44 in 2000
07/17/2001
Biogen Reports Second Quarter 2001 Results
04/12/2001
Biogen Reports Record Results for First Quarter 2001
01/17/2001
Biogen Reports Fourth Quarter and 2000 Results
10/10/2000
Biogen Reports Third Quarter 2000 Results
07/11/2000
Biogen Reports Second Quarter 2000 Results
04/10/2000
Biogen Reports First Quarter 2000 Results
01/13/2000
Biogen Reports Record Fourth Quarter and 1999 Results
10/07/1999
Biogen Reports Third Quarter 1999 Results AVONEX(R) Prescription Growth Drives Earnings Increase
07/08/1999
Biogen Reports Second Quarter 1999 Results Record Revenues and Number of AVONEX(R) Patients Reported
04/08/1999
Biogen Reports Record First Quarter 1999 Results
01/14/1999
Biogen Reports Record Fourth Quarter And 1998 Results
10/05/1998
Biogen Reports Third Quarter 1998 Results
07/09/1998
Biogen Reports Second Quarter 1998 Results
04/08/1998
Biogen Reports First Quarter 1998 Results
01/15/1998
Biogen Reports Record Fourth Quarter and 1997 Results
10/08/1997
Biogen Reports Third Quarter 1997 Results
07/10/1997
Biogen Reports Second Quarter 1997 Results
04/10/1997
Biogen Reports First Quarter 1997 Results And Commencement Of New Clinical Trials
01/14/1997
Biogen Reports Fourth Quarter And 1996 Results
10/09/1996
Biogen Reports Strong Sales Of AVONEX Record Revenues And Earnings In Third Quarter


About BIOGEN
BIOGEN in the Community
Products & Pipeline
Research & Development
News & Media
Career Opportunities